Skip to main content

Multi-Center Phase III Clinical Trials and NCI Cooperative Groups Workshop Summary (2009) / Chapter Skim
Currently Skimming:

Glossary
Pages 105-110

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 105...
... Adjuvant therapies are used to enhance the effect of primary treatment, and would not necessarily be expected to have therapeutic effect in the absence of the primary treatment. Adverse event -- any negative or unwanted effect from a drug, device, or medical test.
Read the entire page →
From page 106...
... Unlike grants, cooperative agreements are utilized when substantial governmental involvement is expected. Cooperative group -- the collection of researchers, cancer centers, academic medical centers, community hospitals, private research institutions, and community physicians who organize to design and implement clinical trials to study new cancer treatments, methods of cancer prevention and early detection, and quality of life issues.
Read the entire page →
From page 107...
... . HCPCS modifier -- An HCPCS code descriptor utilized to provide additional information regarding the service or item identified by the HCPCS code, including specific circumstances that may apply to the service or item.
Read the entire page →
From page 108...
... Serious adverse event (SAE) -- an untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability or incapacity, or is a congenital anomaly or birth defect.
Read the entire page →
From page 109...
... Translational research -- the translation of novel findings obtained from scientific medical research into testable hypotheses for evaluation in clinical trials in human subjects. Value-stream mapping -- a lean process visualization technique used to analyze the flow of materials and information through a system.
Read the entire page →

Key Terms

  • clinical trials
  • breast cancer
  • hcpcs code
  • cell lung
  • lung cancer

  • locally advanced
  • receptor tyrosine
  • metastatic cancer
  • epidermal growth
  • treat locally

  • adverse events
  • genetic mutations
  • tyrosine kinase
  • antibody drug
  • factor receptor

  • bill payors
  • targets epidermal
  • growth factor
  • insurance companies
  • monoclonal antibody

  • special protocol
  • trial protocol
  • specific genetic
  • cal trials
  • novel findings

  • biologic license
  • financial risk
  • treat metastatic
  • community hospitals
  • process improvement


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.